HIV Medicine

Aims & Scope

HIV Medicine aims to provide an alternative outlet for publication of international research papers in the field of HIV Medicine, embracing clinical, pharmocological, epidemiological, ethical, preclinical and in vitro studies.

In addition, the journal will commission reviews and other feature articles.

It will focus on evidence-based medicine as the mainstay of successful management of HIV and AIDS.

The journal is specifically aimed at researchers and clinicians with responsibility for treating HIV seropositive patients.

View Aims & Scope

---

Metrics & Ranking

Impact Factor

Year	Value
2024	2.80

Journal Rank

Year	Value
2024	3985

Journal Citation Indicator

Year	Value
2024	1159

SJR (SCImago Journal Rank)

Year	Value
2024	1.123

Quartile

Year	Value
2024	Q1

h-index

Year	Value
2024	88

---

---

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Web of Science
• Medline

---

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Medicine, designed to support cutting-edge academic discovery.

---

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• Late presentation of HIV infection: a consensus definition

  Citation: 390

  Authors: A, T, D, N, M, J, E, M, O, J, A, A, A, D, JK, C, A, F

• Life expectancy of <scp>HIV</scp>‐positive people after starting combination antiretroviral therapy: a meta‐analysis

  Citation: 364

  Authors: S, SJ, J, K, MG

• British HIV Association guidelines for the treatment of HIV‐1‐infected adults with antiretroviral therapy 2008

  Citation: 356

  Authors: BG

• Relative risk of cardiovascular disease among people living with <scp>HIV</scp>: a systematic review and meta‐analysis

  Citation: 352

  Authors: FM, J, J, DP

• Immune restoration disease after the treatment of immunodeficient HIV‐infected patients with highly active antiretroviral therapy

  Citation: 317

  Authors: M.A., N., M., S.A., E.J., I.R., P., J.P., M‐L.

• Decreasing mortality and changing patterns of causes of death in the <scp>S</scp>wiss <scp>HIV C</scp>ohort <scp>S</scp>tudy

  Citation: 316

  Authors: R, M, M, A, H, M, M, A, E, P, M, J, B

• Higher rates of neuropsychiatric adverse events leading to dolutegravir discontinuation in women and older patients

  Citation: 240

  Authors: C, T, M, M, E, H‐J, C

• Tenofovir‐associated renal and bone toxicity

  Citation: 230

  Authors: CLN, AM, IG, S, A, D, SG, MA, JO

• The use of the Framingham equation to predict myocardial infarctions in HIV‐infected patients: comparison with observed events in the D:A:D Study

  Citation: 225

  Authors: MG, N, WM, R, P, A, R, L, S, C, G, O, CA, AN, JD

• Effects of HIV disease on lipid, glucose and insulin levels: results from a large antiretroviral‐naïve cohort

  Citation: 221

  Authors: WM, CM, A, C, C, F, C, SS

---